Swarajya Logo
  • Morning Brief
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • Our Views
  • Magazine
  • Headlines
  • Store

johnson and johnson

Guillain-Barre Syndrome: FDA Issues Warning On Johnson & Johnson's Covid-19 Vaccine Linked To Rare Disorder

Bhaswati Guha Majumder
3y News Brief
image

US Decision To Not Give Emergency Authorisation To Bharat Biotech’s Covaxin Has Nothing To Do With Its Efficacy

Swarajya Staff
4y News Brief
image

Why Pfizer And Moderna CEOs Are Recommending Covid-19 Vaccine Boosters, And Why Some Experts Don't Agree Yet

Bhaswati Guha Majumder
4y News Brief
image

Moderna And Johnson & Johnson May Participate In Yogi Govt's Global Tender To Procure 40 Million Covid Vaccine Doses

Swarajya Staff
4y Insta
image

US FDA Recommends Pause On Johnson & Johnson's Single Dose Vaccine Following Blood Clot Cases

Swarajya Staff
4y Insta
image

All You Need To Know About Johnson & Johnson’s Covid-19 Vaccine Trial In India

Bhaswati Guha Majumder
4y Science
image

Big Pharma In Big Mess: A Crisis Of Credibility 

Rajeev Srinivasan
5y Magazine
image

Troubles Haven’t Ended For Johnson & Johnson: Baby Shampoo Fails Watchdog’s Quality Tests  

Swarajya Staff
6y Insta
image

When Stocks Get ‘Powdered’: Johnson & Johnson In Damage-Control Mode Amid Panic-Driven $40 Billion Share Sell-Off 

Swarajya Staff
6y Insta
image

Cancer-Causing Asbestos In Johnson & Johnson’s Baby Powder? India Set To Investigate Following Reuters Report

Swarajya Staff
6y Insta
image

Johnson & Johnson To Pay Compensation For Faulty Implants Following Government Order

Swarajya Staff
6y Insta
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo